Nutrien Ltd. $NTR Stock Holdings Lowered by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. reduced its holdings in Nutrien Ltd. (NYSE:NTR) by 3.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,202,538 shares of the company’s stock after selling 45,418 shares during the quarter. Epoch Investment Partners Inc. owned 0.25% of Nutrien worth $74,221,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Montag A & Associates Inc. raised its holdings in shares of Nutrien by 310.7% in the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after purchasing an additional 320 shares in the last quarter. Sfam LLC bought a new stake in shares of Nutrien in the 4th quarter worth approximately $37,000. Eastern Bank raised its holdings in shares of Nutrien by 133.0% in the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock worth $43,000 after purchasing an additional 399 shares in the last quarter. Harbour Investments Inc. raised its holdings in shares of Nutrien by 97.2% in the 4th quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock worth $43,000 after purchasing an additional 347 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Nutrien by 42.4% in the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after purchasing an additional 219 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Stock Performance

Shares of NTR opened at $67.65 on Friday. The company’s 50 day moving average price is $71.34 and its 200 day moving average price is $69.17. Nutrien Ltd. has a 52 week low of $53.03 and a 52 week high of $85.36. The company has a market capitalization of $32.47 billion, a PE ratio of 13.78, a PEG ratio of 0.62 and a beta of 0.60. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24.

Nutrien (NYSE:NTR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.30 billion. During the same period in the previous year, the firm posted $0.11 earnings per share. The firm’s revenue was up 18.5% on a year-over-year basis. Research analysts expect that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be paid a $0.55 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.3%. Nutrien’s dividend payout ratio is 44.81%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. UBS Group dropped their target price on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research report on Monday, May 11th. Barclays lifted their target price on shares of Nutrien from $70.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 3rd. Morgan Stanley lifted their target price on shares of Nutrien from $77.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 8th. Royal Bank Of Canada lifted their target price on shares of Nutrien from $80.00 to $85.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 7th. Finally, Berenberg Bank set a $65.00 target price on shares of Nutrien and gave the stock a “hold” rating in a research report on Wednesday. Eleven analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $81.71.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.